ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank13
3Y CAGR-27.3%
5Y CAGR-10.6%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-27.3%/yr
vs -10.4%/yr prior
5Y CAGR
-10.6%/yr
Recent deceleration
Acceleration
-16.9pp
Decelerating
Percentile
P13
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 8.24% | -47.5% |
| 2025 | 15.69% | -9.4% |
| 2024 | 17.33% | -19.3% |
| 2023 | 21.47% | +93.3% |
| 2022 | 11.10% | -23.1% |
| 2021 | 14.44% | +33.4% |
| 2020 | 10.83% | -67.5% |
| 2019 | 33.28% | +531.3% |
| 2018 | 5.27% | +175.0% |
| 2017 | -7.03% | - |